<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To estimate the incidence of diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> in relation to <z:hpo ids='HP_0000488'>retinopathy</z:hpo> grade at first examination and other prognostic characteristics </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: This was a dynamic cohort study of 20,686 people with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> who had annual <z:chebi fb="46" ids="15035">retinal</z:chebi> photography up to 14 times between 1990 and 2006 </plain></SENT>
<SENT sid="2" pm="."><plain>Cumulative and annual incidence rates were estimated using life tables, and risk factors for progression were identified using Cox regression analysis </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Of 20,686 patients without proliferative diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PDR</z:e>) or sight-threatening <z:e sem="disease" ids="C0730362" disease_type="Disease or Syndrome" abbrv="">maculopathy</z:e> at their first <z:chebi fb="46" ids="15035">retinal</z:chebi> examination (baseline), 16,444 (79%) did not have <z:hpo ids='HP_0000488'>retinopathy</z:hpo>, 3,632 (18%) had nonproliferative <z:hpo ids='HP_0000488'>retinopathy</z:hpo>, and 610 (2.9%) had preproliferative <z:hpo ids='HP_0000488'>retinopathy</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>After 5 years, few patients without <z:hpo ids='HP_0000488'>retinopathy</z:hpo> at baseline developed preproliferative <z:hpo ids='HP_0000488'>retinopathy</z:hpo> (cumulative incidence 4.0%), sight-threatening <z:e sem="disease" ids="C0730362" disease_type="Disease or Syndrome" abbrv="">maculopathy</z:e> (0.59%), or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PDR</z:e> (0.68%); after 10 years, the respective cumulative incidences were 16.4, 1.2, and 1.5% </plain></SENT>
<SENT sid="5" pm="."><plain>Among those with nonproliferative (background) <z:hpo ids='HP_0000488'>retinopathy</z:hpo> at baseline, after 1 year 23% developed preproliferative <z:hpo ids='HP_0000488'>retinopathy</z:hpo>, 5.2% developed <z:e sem="disease" ids="C0730362" disease_type="Disease or Syndrome" abbrv="">maculopathy</z:e>, and 6.1% developed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PDR</z:e>; after 10 years, the respective cumulative incidences were 53, 9.6, and 11% </plain></SENT>
<SENT sid="6" pm="."><plain>Patients with nonproliferative <z:hpo ids='HP_0000488'>retinopathy</z:hpo> at baseline were five times more likely to develop preproliferative, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PDR</z:e>, or <z:e sem="disease" ids="C0730362" disease_type="Disease or Syndrome" abbrv="">maculopathy</z:e> than those without <z:hpo ids='HP_0000488'>retinopathy</z:hpo> at baseline (adjusted hazard ratio 5.0 [95% CI 4.4-5.6]) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Few patients without diabetic <z:hpo ids='HP_0000488'>retinopathy</z:hpo> at the initial screening examination developed preproliferative <z:hpo ids='HP_0000488'>retinopathy</z:hpo>, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PDR</z:e>, or sight-threatening <z:e sem="disease" ids="C0730362" disease_type="Disease or Syndrome" abbrv="">maculopathy</z:e> after 5-10 years of follow-up </plain></SENT>
<SENT sid="8" pm="."><plain>Screening intervals longer than a year may be appropriate for such patients </plain></SENT>
</text></document>